| 000 | 01339 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518033024.0 | ||
| 264 | 0 | _c20200710 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1573-4935 | ||
| 024 | 7 |
_a10.1042/BSR20182105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDu, Pengqiang | |
| 245 | 0 | 0 |
_aAssociation between the UGT1A1*28 allele and hyperbilirubinemia in HIV-positive patients receiving atazanavir: a meta-analysis. _h[electronic resource] |
| 260 |
_bBioscience reports _c05 2019 |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAtazanavir Sulfate _xadverse effects |
| 650 | 0 | 4 |
_aBilirubin _xblood |
| 650 | 0 | 4 |
_aBiomarkers, Pharmacological _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenetic Heterogeneity _xdrug effects |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlucuronosyltransferase _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperbilirubinemia _xblood |
| 650 | 0 | 4 |
_aJaundice, Obstructive _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aWang, Aifeng | |
| 700 | 1 | _aMa, Yongcheng | |
| 700 | 1 | _aLi, Xingang | |
| 773 | 0 |
_tBioscience reports _gvol. 39 _gno. 5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BSR20182105 _zAvailable from publisher's website |
| 999 |
_c29566531 _d29566531 |
||